Worksite clinics 2.0? Interview with Crossover CEO Scott Shreeve
https://healthbb.files.wordpress.com/2016/03/shreeve-crossover-mp3-3_20_16-1-59-pm.mp3 I first encountered Dr. Scott Shreeve about a decade ago when he put forth an expansive framework for Health 2.0. We caught up again recently to discuss his next generation worksite clinic company, Crossover Health. I really enjoyed the podcast interview and am bullish on the company. Here’s what we discussed: (0:10) How does Crossover compare to a traditional primary care practice, patient centered medical home, concierge practice, urgent care center or traditional worksite clinic? (0:54) You have an onsite model and near site ...
Source: Health Business Blog - March 21, 2016 Category: Health Management Authors: dewe67 Tags: Entrepreneurs Physicians Podcast norwest venture partners primary care Source Type: blogs

Second breakfast: The Hobbits were on to something
From MedPage Today (For Kids, Two Breakfasts Healthier Than None) Middle-school students who routinely ate two breakfasts — one at home and one at school — were still more likely to maintain a healthy body weight than those who skipped breakfast, a longitudinal study found. Previous studies have shown a link between skipping breakfast and weight gain, but the mechanisms behind this phenomenon are not well understood either, Schwartz and colleagues said. One reason may be reverse causality: Overweight individuals skip breakfast thinking it will help them lose weight. Another theory is that skipping breakfast lea...
Source: Health Business Blog - March 18, 2016 Category: Health Management Authors: dewe67 Tags: Amusements Research Hobbit lord of the rings Source Type: blogs

Collaboration in pre-clinical and clinical development: interview with Dalvir Gill
  https://healthbb.files.wordpress.com/2016/03/hbdew046-david-williams-interviews-transcelerate.mp3 TransCelerate BioPharma is a pharmaceutical company collaboration that addresses key issues in clinical development that benefit everyone. Now six members have decided to extend the concept to the pre-clinical realm by establishing BioCelerate. Their goal is to compress time to market, reduce cost, and increase the predictive value of preclinical data. I spoke recently with TransCelerate’s CEO Dalvir Gill about TransCelerate and the new BioCelerate initiative. As CEO of both organization, he’s in a good p...
Source: Health Business Blog - March 16, 2016 Category: Health Management Authors: dewe67 Tags: Pharma Research Source Type: blogs